시장보고서

상품코드

1771586

미국의 상처용 젤 시장 규모, 점유율·동향 분석 보고서 : 제품별, 항균 특성별, 용도별, 최종 용도별, 구입 모드별, 유통 채널별, 부문 예측(2025-2033년)

U.S. Wound Gel Market Size, Share & Trends Analysis Report By Product (Dressings, Gels), By Antimicrobial Properties (Silver (Ag+), Non-Silver), By Application, By End-use, By Mode Of Purchase, By Distribution Channel, And Segment Forecasts, 2025 - 2033

발행일: 2025년 06월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국의 상처용 젤 시장 규모·동향 :

미국의 상처용 젤 시장 규모는 2024년에 21억 1,000만 달러에 달했고, 2025년부터 2033년까지 연평균 복합 성장률(CAGR) 5.71%를 나타내 2033년에는 34억 7,000만 달러에 달할 것으로 예측됩니다.

이 성장의 배경에는 만성 상처의 유병률 상승, 고급 상처 케어 솔루션에 대한 수요 증가, 노인 인구 증가, 치유 효과를 높이는 하이드로겔 제제의 지속적인 기술 혁신이 있습니다.

미국 인구조사국의 데이터에 따르면 2025년까지 인구의 평균 연령은 40세에 이르며, 65세 이상의 고령자는 약 6,000만 명으로 총 인구의 18%를 차지할 것으로 예측됩니다. 그중 4%가 80세 이상이 될 전망입니다.

미국의 군사 및 방위 분야에 있어서의 상처용 젤 제품에 대한 수요 증가는 주로 전투나 현장에서의 활동이라고 하는 특수로 리스크가 높은 성질 때문에 중요한 시장 성장 촉진요인으로서 부상하고 있습니다. 불가능한 가혹한 환경에서는 즉각적이고 효율적이며 감염에 강한 치료가 필요합니다.

또한 미국 국방부는 바이오 테크놀로지 기업과 협력하여 전장에서의 사용에 특화된 효소 기반과 항균성 상처용 젤 등 첨단 하이드로겔 제제를 개발하고 있습니다. 오라세 상처용 젤은 당초 우지충 유래의 재조합 효소 탈마제를 특징으로 하고 있습니다.

시장 계통 전망
- 상위 시장 전망
- 보조 시장 전망
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 시장 기회 분석
- 시장 과제 분석
미국의 상처용 젤 시장 분석 도구
- 업계 분석 - Porter's Five Forces 분석
- PESTEL 분석

제4장 미국의 상처용 젤 시장 : 제품 추정·동향 분석

부문 대시보드
미국의 상처용 젤 시장 변동 분석
미국의 상처용 젤 시장 규모와 동향 분석(제품별, 2021-2033년)
드레싱
- 하이드로겔 드레싱
- 겔화 섬유 드레싱
- 기타
겔

제5장 미국의 상처용 젤 시장 : 항균 특성 추정·동향 분석

부문 대시보드
미국의 상처용 젤 시장 변동 분석
미국의 상처용 젤 시장 규모와 동향 분석(항균 특성별, 2021-2033년)
은(Ag)
은 이외

제6장 미국의 상처용 젤 시장 : 용도 추정·동향 분석

부문 대시보드
미국의 상처용 젤 시장 변동 분석
미국의 상처용 젤 시장 규모와 동향 분석(용도별, 2021-2033년)
만성 상처
- 당뇨병성 족부 궤양(DFU)
- 욕창
- 다리 궤양
급성 상처
- 외과 절개
- 화상
- 열상, 찰과상

제7장 미국의 상처용 젤 시장 : 유통 채널 추정·동향 분석

부문 대시보드
미국의 상처용 젤 시장 변동 분석
미국의 상처용 젤 시장 규모와 동향 분석(유통 채널별, 2021-2033년)
온라인
오프라인

제8장 미국의 상처용 젤 시장 : 구입 모드 추정·동향 분석

부문 대시보드
미국의 상처용 젤 시장 변동 분석
미국의 상처용 젤 시장 규모와 동향 분석(구매 모드별, 2021-2033년)
처방전
처방전 없음

제9장 미국의 상처용 젤 시장 : 최종 용도 추정·동향 분석

부문 대시보드
미국의 상처용 젤 시장 변동 분석
미국의 상처용 젤 시장 규모와 동향 분석(최종 용도별, 2021-2033년)
병원
전문 클리닉
외래수술센터(ASC)
홈케어
장기 요양 시설
기타

제10장 경쟁 구도

시장 진출기업의 분류
주요 기업 프로파일
기업 점유율 분석(2024년)
- Medline Industries, LP.
- Coloplast Corp
- Molnlycke Health Care AB
- Solventum
- Convatec Inc.
- Cresilon
- Smith Nephew
- B. Braun SE
- DermaRite Industries, LLC.
- Integra LifeSciences Corporation
- Sanara MedTech Inc.

KTH

U.S Wound Gel Market Size & Trends:

The U.S. wound gel market size was estimated at USD 2.11 billion in 2024 and is expected to grow at a CAGR of 5.71% from 2025 to 2033 to reach USD 3.47 billion by 2033. This growth is attributed to the rising prevalence of chronic wounds, increasing demand for advanced wound care solutions, a growing elderly population, and continuous innovations in hydrogel formulations that enhance healing outcomes. In addition, the shift toward outpatient and home-based care and supportive reimbursement policies is further accelerating market expansion.

According to data from the U.S. Census Bureau, by 2025, the population's average age is expected to reach 40 years, with approximately 60 million individuals aged 65 years or older accounting for 18% of the total population. Among them, 4% will be 80 years or older. By 2050, the number of elderly individuals is projected to rise to 80 million, representing 25% of the population aged 65 and above, while those aged 80 and over will comprise 8%.

The increasing demand for wound gel products from the U.S. military and defense sector is emerging as a significant market driver, primarily due to combat and field operations' unique and high-risk nature. Military personnel are frequently exposed to traumatic injuries, including lacerations, burns, and deep wounds, which require immediate, efficient, and infection-resistant treatment in austere environments where traditional surgical care is not readily available. In such scenarios, wound gels offer a practical solution-they are portable, easy to apply, and provide moisture-retentive healing environments that promote faster tissue regeneration while minimizing infection risks.

Furthermore, the U.S. Department of Defense has collaborated with biotechnology firms to develop advanced hydrogel formulations, including enzyme-based or antimicrobial wound gels designed specifically for battlefield use. For instance, in November 2024, the U.S. Army partnered with SolasCure, a Cambridge-based biotechnology company, to evaluate the company's investigational wound care hydrogel, Aurase Wound Gel, in military settings. Aurase wound gel features a recombinant enzyme, tarumase, derived initially from maggots. This enzyme is highly effective in enzymatic debridement, removing dead tissue and preparing the wound bed, offering a biologically inspired solution for wound management that supports natural and alternative healing approaches.

U.S. Wound Gel Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound gel market report based on product, antimicrobial properties, application, distribution channel, mode of purchase, and end-use:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Dressings
- Hydrogel dressing
- Gelling fiber dressings
- Others
Gels
Antimicrobial Properties Outlook (Revenue, USD Million, 2021 - 2033)
Silver (Ag+)
Non-Silver
Application Outlook (Revenue, USD Million, 2021 - 2033)
Chronic Wounds
- Diabetic Foot Ulcers (DFUs)
- Pressure Ulcers
- Stage 1
- Stage 2
- Stage 3
- Stage 4
- Leg Ulcers
Acute Wounds
- Surgical Incisions
- Burns
- 1st Degree
- 2nd Degree
- 3rd Degree
- Lacerations, Abrasions
Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
Prescription
Non-prescription
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Offline
Online
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Specialty Clinics
Ambulatory Surgery Centers
Homecare Settings
Long-Term Care Facilities
Others

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Antimicrobial Properties
- 1.2.3. Application
- 1.2.4. Distribution Channel
- 1.2.5. Mode of Purchase
- 1.2.6. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. U.S. Wound Gel Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Shift towards home healthcare
  - 3.2.1.2. Technological advancements
  - 3.2.1.3. Rising Prevalence of Chronic Diseases
  - 3.2.1.4. Rising aging population in the U.S.
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Stringent regulatory environment
  - 3.2.2.2. Limited reimbursement policies
- 3.2.3. Market Opportunities Analysis
  - 3.2.3.1. Increasing demand for wound gel products from the military and defense sector
- 3.2.4. Market Challenge Analysis
  - 3.2.4.1. Rising competition among industry participants
3.3. U.S. Wound Gel Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal Landscape
  - 3.3.2.2. Economic and Social Landscape
  - 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Gel Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. U.S. Wound Gel Market Movement Analysis
4.3. U.S. Wound Gel Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
4.4. Dressings
- 4.4.1. Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Hydrogel Dressing
  - 4.4.2.1. Hydrogel Dressing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Gelling Fiber Dressings
  - 4.4.3.1. Gelling Fiber Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Others
  - 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Gels
- 4.5.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Wound Gel Market: Antimicrobial Properties Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. U.S. Wound Gel Market Movement Analysis
5.3. U.S. Wound Gel Market Size & Trend Analysis, by Antimicrobial Properties, 2021 to 2033 (USD Million)
5.4. Silver (Ag+)
- 5.4.1. Silver (Ag+) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Non-Silver
- 5.5.1. Non-Silver Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Wound Gel Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. U.S. Wound Gel Market Movement Analysis
6.3. U.S. Wound Gel Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Chronic Wounds
- 6.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.2. Diabetic Foot Ulcers (DFUs)
  - 6.4.2.1. Diabetic Foot Ulcers (DFUs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. Pressure Ulcers
  - 6.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.3.2. Stage 1
    - 6.4.3.2.1. Stage 1 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.3.3. Stage 2
    - 6.4.3.3.1. Stage 2 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.3.4. Stage 3
    - 6.4.3.4.1. Stage 3 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.3.5. Stage 4
    - 6.4.3.5.1. Stage 4 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.4. Leg Ulcers
  - 6.4.4.1. Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Acute Wounds
- 6.5.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. Surgical Incisions
  - 6.5.2.1. Surgical Incisions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Burns
  - 6.5.3.1. Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.5.3.2. 1st Degree
    - 6.5.3.2.1. 1st Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.5.3.3. 2nd Degree
    - 6.5.3.3.1. 2nd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.5.3.4. 3rd Degree
    - 6.5.3.4.1. 3rd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.4. Lacerations, Abrasions
  - 6.5.4.1. Lacerations, Abrasions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Wound Gel Market: Distribution Channel Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. U.S. Wound Gel Market Movement Analysis
7.3. U.S. Wound Gel Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
7.4. Online
- 7.4.1. Online Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Offline
- 7.5.1. Offline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Wound Gel Market: Mode of Purchase Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. U.S. Wound Gel Market Movement Analysis
8.3. U.S. Wound Gel Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
8.4. Prescription
- 8.4.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Non-prescription
- 8.5.1. Non-prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. U.S. Wound Gel Market: End Use Estimates & Trend Analysis

9.1. Segment Dashboard
9.2. U.S. Wound Gel Market Movement Analysis
9.3. U.S. Wound Gel Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.4. Hospitals
- 9.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Specialty Clinics
- 9.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Ambulatory Surgery Center
- 9.6.1. Ambulatory Surgery Center Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. Homecare Settings
- 9.7.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.8. Long-Term Care Facilities
- 9.8.1. Long-Term Care Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.9. Others
- 9.9.1. Long-term Care (residential living setting) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Market Participant Categorization
10.2. Key Company Profiles
10.3. Company Share Analysis, 2024
- 10.3.1. Medline Industries, LP.
  - 10.3.1.1. Company Overview
  - 10.3.1.2. Financial Performance
  - 10.3.1.3. Product Benchmarking
  - 10.3.1.4. Strategic Initiatives
- 10.3.2. Coloplast Corp
  - 10.3.2.1. Company Overview
  - 10.3.2.2. Financial Performance
  - 10.3.2.3. Product Benchmarking
  - 10.3.2.4. Strategic Initiatives
- 10.3.3. Molnlycke Health Care AB
  - 10.3.3.1. Company Overview
  - 10.3.3.2. Financial Performance
  - 10.3.3.3. Product Benchmarking
  - 10.3.3.4. Strategic Initiatives
- 10.3.4. Solventum
  - 10.3.4.1. Company Overview
  - 10.3.4.2. Financial Performance
  - 10.3.4.3. Product Benchmarking
  - 10.3.4.4. Strategic Initiatives
- 10.3.5. Convatec Inc.
  - 10.3.5.1. Company Overview
  - 10.3.5.2. Financial Performance
  - 10.3.5.3. Product Benchmarking
  - 10.3.5.4. Strategic Initiatives
- 10.3.6. Cresilon
  - 10.3.6.1. Company Overview
  - 10.3.6.2. Financial Performance
  - 10.3.6.3. Product Benchmarking
  - 10.3.6.4. Strategic Initiatives
- 10.3.7. Smith+Nephew
  - 10.3.7.1. Company Overview
  - 10.3.7.2. Financial Performance
  - 10.3.7.3. Product Benchmarking
  - 10.3.7.4. Strategic Initiatives
- 10.3.8. B. Braun SE
  - 10.3.8.1. Company Overview
  - 10.3.8.2. Financial Performance
  - 10.3.8.3. Product Benchmarking
  - 10.3.8.4. Strategic Initiatives
- 10.3.9. DermaRite Industries, LLC.
  - 10.3.9.1. Company Overview
  - 10.3.9.2. Financial Performance
  - 10.3.9.3. Product Benchmarking
  - 10.3.9.4. Strategic Initiatives
- 10.3.10. Integra LifeSciences Corporation
  - 10.3.10.1. Company Overview
  - 10.3.10.2. Financial Performance
  - 10.3.10.3. Product Benchmarking
  - 10.3.10.4. Strategic Initiatives
- 10.3.11. Sanara MedTech Inc.
  - 10.3.11.1. Company Overview
  - 10.3.11.2. Financial Performance
  - 10.3.11.3. Product Benchmarking
  - 10.3.11.4. Strategic Initiatives